Pfizer appoints new chief financial officer

Pfizer (NYSE: PFE) has named David M. Denton as its new chief financial officer (CFO) and executive vice president.

Denton, who now serves as CFO of Lowe’s Companies, will officially take the role on May 2.

Before taking on his role at Lowe’s (NYSE:LOW), Denton served as the CFO of CVS Health (NYSE:CVS). Denton oversaw CVS’s $70 billion acquisition of the managed health care company Aetna.

Denton has more than 20 years of experience working in the healthcare sector.

Pfizer’s current CFO, Frank D’Amelio, has had a 15-year career at the company.

“Our Company’s continued financial strength is essential to Pfizer’s ability to deliver on our purpose and to create long-term value for all our stakeholders,” said Albert Bourla, Pfizer CEO, in a statement. “Dave brings with him deep financial experience, a track record of achievement and true insights into today’s healthcare system. F…

Read more
  • 0

Medable and CVS Health partner to expand clinical trial access

Medable and CVS Health (NYSE:CVS) announced yesterday that they will collaborate to expand clinical trial access and engagement.

Under the collaboration, Medable’s software platform will be combined with CVS Health’s community reach and experienced MinuteClinic providers to deliver clinical trials in a manner that improves patient access, engagement and retention. According to a news release, CVS Health Clinical Trial Services will manage the relationship.

Medable designed its digital platform to streamline design, recruitment, retention and data quality for decentralized trials, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution.

“Our mission is to bring effective therapies to all patients, regardless of where they live, their social status or race. This collaboration intends to bridge research and science into communities with local access and experience that builds greater trust in hea…

Read more
  • 0